Catalyst Wire Dossier Catalyst Wire Dossier

anti-CD137 antibody

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for anti-CD137 antibody, covering 2011-11-21 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients [Phase 1]

See pricing